share_log

华森制药(002907.SZ)：注射用奥美拉唑钠完成境内生产药品备案

Chongqing Pharscin Pharmaceutical (002907.SZ): Intravenous Omeprazole Sodium Completes Domestic Production Drug Filing.

Gelonghui Finance ·  Jul 24 06:34

Chongqing Pharscin Pharmaceutical (002907.SZ) announced on July 24th that the company recently learned from the website of the National Medical Products Administration that its product, injection-grade omeprazole sodium, has completed domestic drug registration (application for extension of drug validity), and the registration information has been publicly displayed on the website of the National Medical Products Administration. Injection-grade omeprazole sodium is a classic medication for upper gastrointestinal bleeding and is clinically necessary. It is a product on the national medical insurance list and has been recommended in multiple guidelines. It is the only proton pump inhibitor that has entered the national essential drug list and has a wide range of applications.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment